Table 1 Sociodemographic characteristics of participants who responded to the surveys
Short-term survey | Long-term survey | Follow-up survey | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
mRNA | Vector | Comp | mRNA | Vector | Comp | Homol. mRNA | Homol. vector | Heterol. | Comp | |||||||
BNT | MOD | AZ | JAN | BNT | MOD | AZ | JAN | BNT BNT | MOD MOD | AZ AZ | AZ BNT | AZ MOD | ||||
N | 2044 | 687 | 177 | 155 | 203 | 2002 | 689 | 192 | 159 | 337 | 5539 | 1342 | 471 | 1382 | 879 | 378 |
Gender (%) | ||||||||||||||||
Female | 55.9 | 62.6 | 36.7 | 41.3 | 59.1 | 56.0 | 61.4 | 37.0 | 42.1 | 58.2 | 58.8 | 61.2 | 41.0 | 61.9 | 60.4 | 58.2 |
Male | 44.0 | 37.1 | 63.3 | 58.7 | 40.4 | 44.0 | 38.5 | 63.0 | 57.9 | 41.5 | 41.1 | 38.5 | 59.0 | 38.1 | 39.5 | 41.5 |
Diverse | 0.0 | 0.3 | 0.0 | 0.0 | 0.5 | 0.0 | 0.1 | 0.0 | 0.0 | 0.3 | 0.1 | 0.4 | 0.0 | 0.0 | 0.1 | 0.3 |
Age | ||||||||||||||||
Mean | 42.1 | 41.4 | 46.1 | 39.2 | 49.8 | 44.6 | 41.7 | 48.4 | 39.7 | 50.1 | 45.6 | 44.6 | 57.3 | 48.9 | 48.4 | 50.8 |
SD | 14.8 | 14.4 | 15.9 | 12.9 | 14.8 | 15.3 | 14.4 | 16.2 | 12.9 | 14.5 | 15.2 | 14.3 | 15.4 | 13.6 | 14.3 | 14.5 |
No pre-existing diseases (%) | ||||||||||||||||
44.8 | 44.7 | 48.0 | 60.0 | 37.4 | 40.0 | 44.1 | 42.2 | 61.0 | 33.5 | 38.9 | 39.9 | 29.9 | 37.4 | 41.9 | 32.8 | |
m-SCQ-D | ||||||||||||||||
Median | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
IQR | 0–2 | 0–2 | 0–2 | 0–2 | 0–2 | 0–2 | 0–2 | 0–2 | 0–2 | 0–2 | 0–2 | 0–2 | 0–2 | 0–2 | 0–2 | 0–2 |
BMI | ||||||||||||||||
Mean | 25.4 | 25.7 | 25.2 | 25.1 | 26.1 | 25.8 | 25.8 | 25.6 | 25.2 | 26.0 | 25.8 | 25.9 | 26.8 | 25.6 | 25.9 | 25.8 |
SD | 5.4 | 5.4 | 4.3 | 4.0 | 6.1 | 5.6 | 5.4 | 4.6 | 4.2 | 5.8 | 5.4 | 5.4 | 5.3 | 4.9 | 5.2 | 5.7 |
NA | 27 | 16 | 3 | 1 | 4 | 28 | 13 | 2 | 1 | 7 | 59 | 21 | 6 | 14 | 1 | 6 |
Participants with other vaccinations 8 weeks before first vaccination (%) | ||||||||||||||||
5.8 | 4.8 | 7.9 | 3.2 | 31.6 | 5.7 | 4.6 | 7.3 | 3.1 | 31.8 | 7.2 | 4.8 | 5.1 | 6.2 | 7.3 | 32.6 | |